Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Clin Cancer Res. 2023 Oct 13;29(20):4230-4241. doi: 10.1158/1078-0432.CCR-22-0906.
Clin Cancer Res. 2023.
PMID: 37199721
Free PMC article.
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells.
Romine KA, MacPherson K, Cho HJ, Kosaka Y, Flynn PA, Byrd KH, Coy JL, Newman MT, Pandita R, Loo CP, Scott J, Adey AC, Lind EF.
Romine KA, et al.
Leukemia. 2023 Mar;37(3):580-592. doi: 10.1038/s41375-023-01808-0. Epub 2023 Jan 21.
Leukemia. 2023.
PMID: 36681742
Free PMC article.
Item in Clipboard
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Flynn PA, Long MD, Kosaka Y, Long N, Mulkey JS, Coy JL, Agarwal A, Lind EF.
Flynn PA, et al.
Front Immunol. 2024 Mar 1;15:1297338. doi: 10.3389/fimmu.2024.1297338. eCollection 2024.
Front Immunol. 2024.
PMID: 38495876
Free PMC article.
Item in Clipboard
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Flynn PA, Long MD, Kosaka Y, Mulkey JS, Coy JL, Agarwal A, Lind EF.
Flynn PA, et al.
bioRxiv [Preprint]. 2023 Sep 22:2023.09.19.558512. doi: 10.1101/2023.09.19.558512.
bioRxiv. 2023.
PMID: 37781631
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite